Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Spencer

Showing results (411-420 of 420) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 420 results.
The New England Journal of Medicine|March 11, 2021
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid CancersEric J Duncavage, Molly C Schroeder, Michele O'Laughlin, et al.
Nature|June 1, 2022
Clonal dynamics of haematopoiesis across the human lifespanEmily Mitchell, Michael Spencer Chapman, Nicholas Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2021
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypesFrancesca Ferraro, Christopher A Miller, Keegan A Christensen, et al.
Pediatric Rheumatology Online Journal|June 15, 2017
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North AmericaC H Spencer, K Rouster-Stevens, H Gewanter, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|December 5, 2013
Clinical genomicist workstationMukesh K Sharma, Joshua Phillips, Saurabh Agarwal, et al.
The Journal of Molecular Diagnostics : JMD|November 12, 2013
Validation of a next-generation sequencing assay for clinical molecular oncologyCatherine E Cottrell, Hussam Al-Kateb, Andrew J Bredemeyer, et al.
Annals of the Rheumatic Diseases|September 28, 2022
Low copy numbers of complement <i>C4</i> and <i>C4A</i> deficiency are risk factors for myositis, its subgroups and autoantibodiesDanlei Zhou, Emily H King, Simon Rothwell, et al.
JAMA|August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid LeukemiaJeffery M Klco, Christopher A Miller, Malachi Griffith, et al.
Science Translational Medicine|February 23, 2022
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemiaMelissa M Berrien-Elliott, Jennifer A Foltz, David A Russler-Germain, et al.
The New England Journal of Medicine|May 3, 2013
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, Timothy J Ley, Christopher Miller, et al.
Pageof 42

Showing results (411-420 of 420) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 420 results.
The New England Journal of Medicine|March 11, 2021
Genome Sequencing as an Alternative to Cytogenetic Analysis in Myeloid CancersEric J Duncavage, Molly C Schroeder, Michele O'Laughlin, et al.
Nature|June 1, 2022
Clonal dynamics of haematopoiesis across the human lifespanEmily Mitchell, Michael Spencer Chapman, Nicholas Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2021
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypesFrancesca Ferraro, Christopher A Miller, Keegan A Christensen, et al.
Pediatric Rheumatology Online Journal|June 15, 2017
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North AmericaC H Spencer, K Rouster-Stevens, H Gewanter, et al.
AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|December 5, 2013
Clinical genomicist workstationMukesh K Sharma, Joshua Phillips, Saurabh Agarwal, et al.
The Journal of Molecular Diagnostics : JMD|November 12, 2013
Validation of a next-generation sequencing assay for clinical molecular oncologyCatherine E Cottrell, Hussam Al-Kateb, Andrew J Bredemeyer, et al.
Annals of the Rheumatic Diseases|September 28, 2022
Low copy numbers of complement <i>C4</i> and <i>C4A</i> deficiency are risk factors for myositis, its subgroups and autoantibodiesDanlei Zhou, Emily H King, Simon Rothwell, et al.
JAMA|August 26, 2015
Association Between Mutation Clearance After Induction Therapy and Outcomes in Acute Myeloid LeukemiaJeffery M Klco, Christopher A Miller, Malachi Griffith, et al.
Science Translational Medicine|February 23, 2022
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemiaMelissa M Berrien-Elliott, Jennifer A Foltz, David A Russler-Germain, et al.
The New England Journal of Medicine|May 3, 2013
Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, Timothy J Ley, Christopher Miller, et al.
Pageof 42